Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF

Am J Respir Crit Care Med. 2005 Nov 1;172(9):1228-9; author reply 1229. doi: 10.1164/ajrccm.172.9.951.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Exercise Test
  • Humans
  • Oxyhemoglobins / metabolism*
  • Pulmonary Fibrosis / blood*
  • Pulmonary Fibrosis / drug therapy*
  • Pyridones / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Oxyhemoglobins
  • Pyridones
  • pirfenidone